Literature DB >> 29976636

Overexpression of FGFR1 Promotes Peritoneal Dissemination Via Epithelial-to-Mesenchymal Transition in Gastric Cancer.

Dai Shimizu1,2, Tomoko Saito1, Shuhei Ito1, Takaaki Masuda1, Junji Kurashige1,3, Yosuke Kuroda1, Hidetoshi Eguchi1, Yasuhiro Kodera2, Koshi Mimori4.   

Abstract

BACKGROUND: Peritoneal dissemination (PD) is one of the most common causes of cancer-related mortality in gastric cancer (GC). We aimed to identify PD-associated genes and investigate their role in GC.
MATERIALS AND METHODS: We identified FGFR1 as a putative PD-associated gene using a bioinformatics approach. The biological significance of FGFR1 in epithelial-to-mesenchymal transition (EMT) was evaluated according to the correlation with genes that participated in EMT and FGFR1 knockdown experiments. The associations between FGFR1 expression and the clinicopathological features were examined.
RESULTS: FGFR1 expression positively correlated with SNAI1, VIM and ZEB1 expression, and negatively correlated with CDH1 expression. Knockdown of FGFR1 suppressed the malignant phenotype of GC cells. High FGFR1 expression significantly correlated with the peritoneal lavage cytology and synchronous PD positivity as well as poor prognosis.
CONCLUSION: High FGFR1 expression was associated with PD via promotion of EMT and led to a poor prognosis of GC patients. Copyright
© 2018, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  FGFR1; Gastric cancer; epithelial to mesenchymal transition; peritoneal dissemination

Mesh:

Substances:

Year:  2018        PMID: 29976636      PMCID: PMC6070707          DOI: 10.21873/cgp.20089

Source DB:  PubMed          Journal:  Cancer Genomics Proteomics        ISSN: 1109-6535            Impact factor:   4.069


  34 in total

Review 1.  Review of recent molecular landscape knowledge of gastric cancer.

Authors:  Dai Shimizu; Mitsuro Kanda; Yasuhiro Kodera
Journal:  Histol Histopathol       Date:  2017-04-27       Impact factor: 2.303

2.  Identification of ARL4C as a Peritoneal Dissemination-Associated Gene and Its Clinical Significance in Gastric Cancer.

Authors:  Qingjiang Hu; Takaaki Masuda; Kuniaki Sato; Taro Tobo; Sho Nambara; Shinya Kidogami; Naoki Hayashi; Yosuke Kuroda; Shuhei Ito; Hidetoshi Eguchi; Hiroshi Saeki; Eiji Oki; Yoshihiko Maehara; Koshi Mimori
Journal:  Ann Surg Oncol       Date:  2017-12-21       Impact factor: 5.344

3.  Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2).

Authors:  Claudia Allemani; Hannah K Weir; Helena Carreira; Rhea Harewood; Devon Spika; Xiao-Si Wang; Finian Bannon; Jane V Ahn; Christopher J Johnson; Audrey Bonaventure; Rafael Marcos-Gragera; Charles Stiller; Gulnar Azevedo e Silva; Wan-Qing Chen; Olufemi J Ogunbiyi; Bernard Rachet; Matthew J Soeberg; Hui You; Tomohiro Matsuda; Magdalena Bielska-Lasota; Hans Storm; Thomas C Tucker; Michel P Coleman
Journal:  Lancet       Date:  2014-11-26       Impact factor: 79.321

Review 4.  Molecular mechanisms of peritoneal dissemination in gastric cancer.

Authors:  Mitsuro Kanda; Yasuhiro Kodera
Journal:  World J Gastroenterol       Date:  2016-08-14       Impact factor: 5.742

5.  GSK-3 phosphorylates delta-catenin and negatively regulates its stability via ubiquitination/proteosome-mediated proteolysis.

Authors:  Minsoo Oh; Hangun Kim; Ilhwan Yang; Ja-Hye Park; Wei-Tao Cong; Moon-Chang Baek; Sonja Bareiss; Hyunkyoung Ki; Qun Lu; Jinhyung No; Inho Kwon; Jung-Kap Choi; Kwonseop Kim
Journal:  J Biol Chem       Date:  2009-08-25       Impact factor: 5.157

6.  Inducible FGFR-1 activation leads to irreversible prostate adenocarcinoma and an epithelial-to-mesenchymal transition.

Authors:  Victor D Acevedo; Rama D Gangula; Kevin W Freeman; Rile Li; Youngyou Zhang; Fen Wang; Gustavo E Ayala; Leif E Peterson; Michael Ittmann; David M Spencer
Journal:  Cancer Cell       Date:  2007-12       Impact factor: 31.743

7.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396

8.  Presence of both alterations in FGFR/FGF and PI3K/AKT/mTOR confer improved outcomes for patients with metastatic breast cancer treated with PI3K/AKT/mTOR inhibitors.

Authors:  Jennifer J Wheler; Johnique T Atkins; Filip Janku; Stacy L Moulder; Philip J Stephens; Roman Yelensky; Vicente Valero; Vincent Miller; Razelle Kurzrock; Funda Meric-Bernstam
Journal:  Oncoscience       Date:  2016-06-30

9.  Different clinical significance of FGFR1-4 expression between diffuse-type and intestinal-type gastric cancer.

Authors:  Mikito Inokuchi; Hideaki Murase; Sho Otsuki; Tatsuyuki Kawano; Kazuyuki Kojima
Journal:  World J Surg Oncol       Date:  2017-01-05       Impact factor: 2.754

10.  Cell size and invasion in TGF-beta-induced epithelial to mesenchymal transition is regulated by activation of the mTOR pathway.

Authors:  Samy Lamouille; Rik Derynck
Journal:  J Cell Biol       Date:  2007-07-23       Impact factor: 10.539

View more
  6 in total

Review 1.  Update on molecular biomarkers for diagnosis and prediction of prognosis and treatment responses in gastric cancer.

Authors:  Masahiro Sasahara; Mitsuro Kanda; Yasuhiro Kodera
Journal:  Histol Histopathol       Date:  2021-03-09       Impact factor: 2.303

2.  circRAPGEF5 Contributes to Papillary Thyroid Proliferation and Metastatis by Regulation miR-198/FGFR1.

Authors:  Weiwei Liu; Ji Zhao; Mingming Jin; Ming Zhou
Journal:  Mol Ther Nucleic Acids       Date:  2019-01-15

3.  miRNA-34b/c regulates mucus secretion in RSV-infected airway epithelial cells by targeting FGFR1.

Authors:  Wenkai Li; Xizi Du; Yu Yang; Lin Yuan; Ming Yang; Ling Qin; Leyuan Wang; Kai Zhou; Yang Xiang; Xiangping Qu; Huijun Liu; Xiaoqun Qin; Gelei Xiao; Chi Liu
Journal:  J Cell Mol Med       Date:  2021-10-12       Impact factor: 5.310

4.  A novel small molecule RK-019 inhibits FGFR2-amplification gastric cancer cell proliferation and induces apoptosis in vitro and in vivo.

Authors:  Jun Zeng; Kai Ran; Xinyue Li; Longyue Tao; Qiwei Wang; Jiangtao Ren; Rong Hu; Yongxia Zhu; Zhihao Liu; Luoting Yu
Journal:  Front Pharmacol       Date:  2022-09-21       Impact factor: 5.988

Review 5.  Proteomic Technology "Lens" for Epithelial-Mesenchymal Transition Process Identification in Oncology.

Authors:  Monica Neagu; Carolina Constantin; Marinela Bostan; Constantin Caruntu; Simona Rebeca Ignat; Sorina Dinescu; Marieta Costache
Journal:  Anal Cell Pathol (Amst)       Date:  2019-10-29       Impact factor: 2.916

6.  Hsa_circRNA_0000518 facilitates breast cancer development via regulation of the miR-326/FGFR1 axis.

Authors:  Jing Jiang; Hui Lin; Shenghong Shi; Ying Hong; Xianan Bai; Xuchen Cao
Journal:  Thorac Cancer       Date:  2020-10-01       Impact factor: 3.500

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.